What does Cont. Chemicals do?

Continental Chemicals Ltd is a micro-cap company in the software products industry, primarily manufacturing soaps and detergents. As of March 2025, it reported net sales and profit of 0 Cr, with a market cap of Rs 15 Cr.

Overview:<BR>Continental Chemicals Ltd is a micro-cap company operating in the software products industry, primarily involved in the manufacturing of soaps and detergents.<BR><BR>History:<BR>Established in 1984 as a Public Limited Company, Continental Chemicals Ltd commenced manufacturing activities in 1985. The company initially exported over five million tons of soaps and detergents to the erstwhile Soviet Union and supplied various units of the Government of India. The latest quarterly results reported net sales and net profit of 0 Cr for March 2025.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2025)<BR>- Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap value: Rs 15 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 16.00<BR>- Industry P/E: 13<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.59<BR>- Return on Equity: 8.75%<BR>- Price to Book: 3.04<BR><BR>Contact Details:<BR>- Address: A-7 Sector-7, Gautam Buddh Nagar Noida Uttar Pradesh : 201301<BR>- Tel: 91-120-2423316<BR>- Email: info@continentalsoft.com<BR>- Website: http://www.continentalchemicalsltd.com

Who are in the management team of Cont. Chemicals?

As of March 2023, the management team of Cont. Chemicals includes Pradeep Chopra (Chairman), Naresh K Chibba (Managing Director), Sunaina Chibba, Akshat Bhaskar, and Aditya Vikram Chibba. Only Naresh K Chibba receives remuneration, totaling Rs. 11.76 lacs.

As of March 2023, the management team of Cont. Chemicals includes the following individuals:<BR><BR>1. Pradeep Chopra - Chairman & Independent Director<BR>2. Naresh K Chibba - Managing Director<BR>3. Sunaina Chibba - Non-Executive Director<BR>4. Akshat Bhaskar - Independent Director<BR>5. Aditya Vikram Chibba - Non-Executive Director<BR><BR>Naresh K Chibba is the only member of the management team receiving remuneration, which amounts to Rs. 11.76 lacs.

Has Cont. Chemicals declared dividend?

No Dividend History Available

Who are the peers of the Cont. Chemicals?

Peers of Cont. Chemicals include Oracle Fin.Serv., C.E. Info System, Tanla Platforms, Moschip Tech., Nucleus Soft., Indo-City Info., Hind.Bio Science, and First Fintec. Hind.Bio Science has the highest 1-year return at 19.58%, while Tanla Platforms has the lowest at -32.80%, with Cont. Chemicals at -7.18%.

Peers: The peers of Cont. Chemicals are Oracle Fin.Serv., C.E. Info System, Tanla Platforms, Moschip Tech., Nucleus Soft., Indo-City Info., Hind.Bio Science, and First Fintec.<BR><BR>Quality Snapshot: Excellent management risk is observed at Oracle Fin.Serv. and Nucleus Soft., while Good management risk is found at C.E. Info System and Tanla Platforms. Average management risk is noted at Tanla Platforms, while Below Average management risk is present at Moschip Tech., Indo-City Info., Hind.Bio Science, and First Fintec. Growth is rated as Good for C.E. Info System and Tanla Platforms, while Below Average growth is seen at Oracle Fin.Serv., Nucleus Soft., Moschip Tech., Indo-City Info., Hind.Bio Science, and First Fintec. Capital Structure is Excellent for Oracle Fin.Serv., C.E. Info System, and Nucleus Soft., while Below Average capital structure is noted for Moschip Tech., Indo-City Info., Hind.Bio Science, and First Fintec.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Hind.Bio Science at 19.58%, while the lowest is Tanla Platforms at -32.80%. Cont. Chemicals has a 1-year return of -7.18%, which is higher than Tanla Platforms but lower than Hind.Bio Science. Additionally, the six-month return is negative for Oracle Fin.Serv., Tanla Platforms, Moschip Tech., Indo-City Info., and First Fintec.

Is Cont. Chemicals overvalued or undervalued?

As of April 25, 2023, Cont. Chemicals is rated as risky and overvalued with a PE ratio of 15.52, an EV to EBIT of -12.57, and a year-to-date return of -29.22%, contrasting sharply with the Sensex's 5.63% gain.

As of 25 April 2023, the valuation grade for Cont. Chemicals has moved from does not qualify to risky. The company is currently assessed as overvalued. Key ratios include a PE ratio of 15.52, an EV to EBIT of -12.57, and a ROE of 8.75%. <BR><BR>In comparison to peers, MMTC has a significantly higher PE ratio of 119.39, while PTC India stands out with a much lower PE of 9.02 and is rated very attractive. The recent performance of Cont. Chemicals shows a year-to-date return of -29.22%, contrasting with a 5.63% gain in the Sensex, further reinforcing the notion that the stock is overvalued in the current market environment.

What is the technical trend for Cont. Chemicals?

As of June 6, 2025, the technical trend for Cont. Chemicals is mildly bearish, supported by bearish MACD indicators, moving averages, and Bollinger Bands across weekly and monthly time frames.

As of 6 June 2025, the technical trend for Cont. Chemicals has changed from bearish to mildly bearish. The weekly MACD remains bearish, and the monthly MACD is also bearish, indicating persistent downward momentum. The daily moving averages are bearish, further supporting the negative outlook. Bollinger Bands and KST both show mildly bearish signals on both weekly and monthly time frames. The Dow Theory also aligns with this stance, indicating a mildly bearish trend. Overall, the current technical stance is mildly bearish, with key indicators such as MACD and moving averages driving this assessment.

Who are the top shareholders of the Cont. Chemicals?

The top shareholder of Cont. Chemicals is Aditya Vikram Chibba, who holds 55.66% of the shares. Promoters own the majority, with individual investors holding 37.62%, and there are no pledged holdings or investments from mutual funds or foreign institutional investors.

The top shareholders of Cont. Chemicals primarily consist of promoters, with Aditya Vikram Chibba holding the largest share at 55.66%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. Additionally, individual investors collectively hold 37.62% of the shares.

How big is Cont. Chemicals?

As of 24th July, Continental Chemicals Ltd has a market capitalization of 17.00 Cr, with recent net sales of 0.35 Cr and a net loss of 0.30 Cr over the last three quarters. Shareholder's funds are valued at 4.59 Cr, and total assets amount to 5.57 Cr.

As of 24th July, <BR><BR>Market Cap: Continental Chemicals Ltd has a market capitalization of 17.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest three quarters is 0.35 Cr, while the sum of Net Profit for the same period shows a loss of 0.30 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is the latest annual period ending March 2024. Shareholder's Funds are valued at 4.59 Cr, and Total Assets amount to 5.57 Cr.

When is the next results date for Cont. Chemicals?

The next results date for Cont. Chemicals is 13 November 2025.

The next results date for Cont. Chemicals is scheduled for 13 November 2025.

How has been the historical performance of Cont. Chemicals?

Cont. Chemicals has experienced declining net sales and operating profit over the years, with a reported loss of -0.76 Cr in March 2025, despite an increase in total assets and liquidity. The company's overall performance reflects challenges in maintaining profitability while managing growth in its asset base.

Answer:<BR>The historical performance of Cont. Chemicals shows a fluctuating trend in its financial metrics over the years.<BR><BR>Breakdown:<BR>Cont. Chemicals reported net sales of 0.22 Cr in March 2025, a decline from 0.42 Cr in March 2024 and 0.44 Cr in March 2023, indicating a downward trend in revenue. Total operating income followed a similar pattern, decreasing from 0.48 Cr in March 2022 to 0.22 Cr in March 2025. The company's total expenditure, excluding depreciation, increased to 0.98 Cr in March 2025 from 0.86 Cr in March 2024, contributing to an operating profit (PBDIT) of -0.76 Cr in March 2025, which is worse than the -0.44 Cr reported in March 2024. Despite these losses, other income rose to 1.35 Cr in March 2025, leading to an overall operating profit of 0.59 Cr. Profit before tax was 0.48 Cr in March 2025, down from 0.61 Cr in March 2024, while profit after tax was 0.44 Cr in March 2025, slightly lower than 0.52 Cr in March 2024. The company's total assets increased to 6.04 Cr in March 2025 from 5.57 Cr in March 2024, with total liabilities also rising to 6.04 Cr. Cash and cash equivalents stood at 2.98 Cr in March 2025, up from 2.66 Cr in March 2024, reflecting a positive trend in liquidity. Overall, Cont. Chemicals has faced challenges in maintaining sales and profitability, while managing to grow its asset base and liquidity.

Which are the latest news on Cont. Chemicals?

Why is Cont. Chemicals falling/rising?

As of 03-Dec, the stock price of Continental Chemicals Ltd is 73.40, unchanged from the previous session. Despite recent short-term gains, the stock has significantly underperformed year-to-date and over the past three years compared to the Sensex.

As of 03-Dec, the stock price of Continental Chemicals Ltd is currently at 73.40, with no change from the previous trading session. Over the past week, the stock has remained flat with a 0.00% change, while the benchmark Sensex has decreased by 0.59%. In the past month, the stock has shown a positive performance with a gain of 4.86%, contrasting with the Sensex's increase of 1.34%. However, year-to-date, the stock has significantly underperformed, declining by 24.71%, while the Sensex has risen by 8.92%. <BR><BR>In terms of annual performance, the stock has decreased by 6.19%, compared to a 5.27% increase in the Sensex. Over a three-year period, the stock has fallen by 23.54%, while the benchmark has gained 35.37%. Despite this, the stock has shown remarkable growth over the past five years, increasing by 286.32%, compared to the Sensex's 90.68% rise.<BR><BR>Today's performance indicates that the stock has underperformed its sector by 1.42%. Additionally, the stock has experienced erratic trading, having not traded on three out of the last twenty days. While the stock's current price is higher than its 5-day, 20-day, 50-day, and 100-day moving averages, it remains lower than its 200-day moving average. <BR><BR>On a positive note, there has been a significant increase in investor participation, with delivery volume rising by 844.64% on November 21 compared to the 5-day average. The stock is also considered liquid enough for trading, based on 2% of the 5-day average traded value. <BR><BR>In summary, while the stock has shown some positive movement in the short term, its overall performance remains weak compared to the benchmark and its historical performance, contributing to the perception of a falling stock.